REHOVOT, Israel and BETHESDA, MD., Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB:CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the Company has filed a new patent application titled " COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE THEREOF IN THE TREATMENT OF CANCER" under the Patent Cooperation Treaty (PCT).
Read more at prnewswire.comCNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
